文化大學機構典藏 CCUR:Item 987654321/30330
English  |  正體中文  |  简体中文  |  Items with full text/Total items : 47145/51011 (92%)
Visitors : 13869643      Online Users : 312
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version


    Please use this identifier to cite or link to this item: https://irlib.pccu.edu.tw/handle/987654321/30330


    Title: C型肝炎病毒蛋白酶之小分子抑製劑的電腦模擬篩選和實驗評析
    In Silico Screening and Experimental Evaluation of Small Molecule Inhibitors Against HCV NS3/4A Protease
    Authors: 阮皇章
    Nguyen, Hoang-Chinh
    Contributors: 生物科技研究所
    Keywords: Hepatitis C virus
    small molecule
    inhibitor
    NS3/NS4A protease
    docking
    Date: 2015-06
    Issue Date: 2015-08-20 15:03:47 (UTC+8)
    Abstract: Hepatitis C virus (HCV) is the major cause of chronic liver diseases, including cirrhosis, liver failure, and liver cancer with over 170 million infected people worldwide. There is not any vaccine available for HCV treatment. NS3/4A serine protease is essential for viral replication, which shows a promising drug target for developing direct-acting anti-HCV agents. In this study, 150,000 small molecule compounds were extracted from chemical library and screened against NS3/4A protease by structure-based virtual screening (PyRx sofware). Ten compounds with the highest binding affinity were selected and used to evaluate their inhibitory activity by enzyme assay. The NS3/4A protease used for inhibitory kinetic analyses was the recombinant core enzyme, NS3-GSGS-NS4A. Among 10 selected compounds, compound 1 showed the highest inhibitory activity against the NS3/4A protease with IC50 and Ki values of 2.17 μM and 0.92 μM, respectively. Compound 1 was found to be a competitive inhibitor supposed to bind directly to the protease active site. In comparison with the control, the inhibitory activity of compound 1 was two-fold higher than that of hexapeptide, DEMEEC. Our newly identified compound 1 showed a promising anti-HCV agent for further drug development. These data suggested that virtual screening by means of molecular docking may an alternative way in drug discovery and development, which could save time, reduce chemical usage and find candidates efficiently.
    Appears in Collections:[Graduate Institute of Biotechnology ] thesis

    Files in This Item:

    File Description SizeFormat
    index.html0KbHTML520View/Open


    All items in CCUR are protected by copyright, with all rights reserved.


    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback